2023-10-13 // Biden administration awards $500M for new COVID treatments

Go to Article

2023-10-11 // Pharma-backed MinervaX raises €54M as it aims to move its group B Streptococcus vaccine into PhIII

Go to Article

2023-10-09 // Antimicrobial resistance biotech secures $37M with ex-CureVac CEO Franz-Werner Haas at the helm

Go to Article

2023-10-09 // Gates Foundation spends $40M to boost mRNA vaccine production in Africa and beyond

Go to Article

2022-02-10 // A small Seattle biotech wants to take on GlaxoSmithKline’s emerging Shingrix blockbuster

Go to Article

2022-02-07 // Univercells campus in Jumet ready to produce vaccines

Go to Article